Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
NCT: NCT05329350 · RECRUITING
Brief Summary
The Occlutech® mVSD is indicated for percutaneous occlusion of hemodynamically or clinically significant muscular ventricular septal defects. The objectives of the study are: * To confirm the efficacy of Occlutech mVSD in patients requiring transcatheter occlusion (closure) of muscular ventricular septal defects. * To confirm the safety of Occlutech mVSD in patients requiring transcatheter occlusion (closure) of muscular ventricular septal defects.
Frequently Asked Questions
What is Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases?
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases is a clinical trial registered under NCT05329350. Current status: RECRUITING.
What is the status of NCT05329350?
The current status of NCT05329350 (Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases) is: RECRUITING.
When did Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases start?
Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases started on 2022-03-03.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.